MedTrace Logo

Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty

NCT01553097 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2014-12-16

No results posted yet for this study

Summary

This longitudinal project will investigate a common complaint of women who receive chemotherapy for breast cancer- cognitive difficulty. The relationships of fatigue, stress, and depression to cognitive difficulties will be examined. The findings should lead to interventions to decrease the effects of these problematic side effects.

Conditions

Interventions

OTHER

Neurocognitive impairment observation

None - observational

Sponsors & Collaborators

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Mary Jo Grapp, PhD · Virginia Commonwealth University

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01553097 on ClinicalTrials.gov